Skip to content

Lymphatic Injury Visualization in Vascular Surgery

Visualization and Treatment of Lymphatic Injury During Vascular Surgery Procedures in the Groin: A Pilot Study

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07499206
Acronym
LymphFistula-P
Enrollment
60
Registered
2026-03-30
Start date
2026-04-01
Completion date
2027-04-01
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Ischemia, Aneurysm, Hemmorhage, Peripheral Arterial Disease(PAD), Pseudoaneurysm, Vascular Surgical Procedure

Brief summary

This study aims to assess a simple intervention: Visualization of lymphatic injury + treatment (in case of detection). This will generate data on the incidence of intraoperative lymphatic injury and the effect of treatment. This data will then hopefully enable a multi-center RCT to generate high level evidence on this matter.

Detailed description

Gaining arterial access in the groin is a very common surgical procedure for vascular surgeons. To reach the femoral artery, invisible lymphatic vessels are often harmed and in turn lymphatic injuries are created. Due to their transparent color and small size, these injuries remain unseen during surgery and are therefore untreated. These small lymphatic injuries can lead to wound complications including lymphoceles, lymphatic fistulas and surgical site infections (SSI) that are associated with higher morbidity and prolonged hospital stay, even mandating re-interventions in some cases. The investigators hope to reduce wound complication rates by visualizing and directly treating these lymphatic injuries. To be able to detect the injuries, PatentBlau V (E131) will be applied, a blue dye with Swissmedic approval for visualization of lymphatic vessels. Sex differences will be noted and analyzed, gender as a dimension is not relevant.

Interventions

PROCEDUREVisualization of lymphatic injury and treatment of injury (in case of detection)

PatentBlau V application: 2ml will be injected intradermally around the groin wound. After allowing a maximum of 10 minutes for lymphatic uptake of the blue dye, a thorough inspection of the wound will be performed to detect possible lymphatic injuries, which will be visible by the blue color. Direct treatment (e.g. suture, clipping) of visible lymphatic injuries will be performed.

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* adult patients undergoing vascular surgery procedures in the groin * signed informed consent for study participation

Exclusion criteria

* pregnant or lactating women * prior groin surgery * infected surgical site in the groin * necessity for further incisions (e.g. bypass surgery) * incapability of judgement or consent

Design outcomes

Primary

MeasureTime frameDescription
Composite endpoint: Number of participants with wound complications including lymphocele, lymphatic fistula, and surgical site infection (SSI)Up to 30 days postoperativelyWound complications defined as follows: Lymphocele: localized fluid collection at the site of surgical dissection; Lymphatic fistula: persistent external drainage of clear fluid for the wound \> 72h after surgery; Surgical Site Infection (SSI): according to the CDC definitions.

Secondary

MeasureTime frame
Intraoperative incidence of lymphatic injuryIntraoperatively
Rate of re-interventions, defined as further invasive measure in the respective groinUp to 30 days postoperatively
Lenght of hospital stayUp to 30 days postoperatively
30-day mortalityUp to 30 days postoperatively

Countries

Switzerland

Contacts

CONTACTMatteo Giardini, Dr. med.
matteo.giardini@usb.ch+41 61 265 72 22

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026